Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: A review

Journal of Biochemical and Molecular Toxicology

Volumn 26, Issue 2, 2012, Pages 79-86

  Chen, Fei ^a   Hu, Shen Jiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Apoptosis; Cell Cycle; Differentiation; MiR 34a

Indexed keywords

HISTONE DEACETYLASE; JAGGED1; MICRORNA; MICRORNA 34A; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; PROTEIN P53; SIRTUIN 1; UNCLASSIFIED DRUG; WNT1 PROTEIN;

APOPTOSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; B LYMPHOCYTE; BIOGENESIS; CANCER CELL; CANCER CELL CULTURE; CARCINOGENICITY; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELLULAR STRESS RESPONSE; CHROMOSOME 1P; CHROMOSOME DELETION; COLON CANCER; CYTOPLASM; DENDRITIC CELL; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE MUTATION; HUMAN; LEUKEMIA CELL LINE; NEUROBLASTOMA; NONHUMAN; PANCREAS CANCER; PROMOTER REGION; PROSTATE CANCER; REVIEW; SENESCENCE; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; APOPTOSIS; BASE SEQUENCE; CELL CYCLE; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASMS; RNA INTERFERENCE;

EID: 84857624291     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20412     Document Type: Review

References (43)

1. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006; 20: 515-524.
2. Choudhuri S. Small noncoding RNAs: biogenesis, function, and emerging significance in toxicology. J Biochem Mol Toxicol 2010; 243: 195-216.
3. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003; 3: 203-216.
4. Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007; 26: 5017-5022.
5. Sotillo E, Laver T, Mellert H. Myc overexpression brings out unexpected antiapoptotic effects of miR-34a. Oncogene (in press).
6. Bagchi A, Mills AA. The quest for the 1p36 tumor suppressor. Cancer Res 2008; 68: 2551-2556.
7. Ito T, Yagi S, Yamakuchi M. MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun 2010; 398: 735-740.
8. Zhao T, Li J, Chen AF. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator. Am J Physiol Endocrinol Metab 2010; 299: E110-E116.
9. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26: 731-743.
10. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007; 6: 1586-1593.
11. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745-752.
12. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007; 17: 1298-1307.
13. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010; 17: 193-199.
14. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-1134.
15. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007; 67: 8433-8438.
16. Yamakuchi M, Ferlito M, Lowenstein CJ. MiR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008; 105: 13421-13426.
17. Lee J, Padhye A, Sharma A. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J Biol Chem 2010; 28517: 12604-12611.
18. Christoffersen NR, Shalgi R, Frankel LB. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ 2010; 17: 236-245.
19. Ichimura A, Ruike Y, Terasawa K. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells. Mol Pharmacol 2010; 77: 1016-1024.
20. Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ, Brodeur GM. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res 2008; 6: 735-742.
21. Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 2008; 377: 114-119.
22. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 2008; 68: 4123-4132.
23. Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett 2009; 275: 44-53.
24. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007; 104: 15472-15477.
25. Yan D, Zhou X, Chen X. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci 2009; 50: 1559-1565.
26. Maehara K, Yamakoshi K, Ohtani N. Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53. J Cell Biol 2005; 168: 553-560.
27. Zhuang D, Mannava S, Grachtchouk V, Tang WH, Patil S, Wawrzyniak JA. C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene 2008; 27: 6623-6634.
28. Hu H, Wang B, Borde M, Nardone J, Maika S, Allred L, Tucker PW, Rao A. Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol 2006; 7: 819-826.
29. Busslinger M. Transcriptional control of early B cell development. Annu Rev Immunol 2004; 22: 55-79.
30. Rao DS, O'Connell RM, Baltimore D. microRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity 2010; 33: 48-59.
31. Hashimi ST, Fulcher JA, Chang MH, Gov L, Wang S, Lee B. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 2009; 114: 404-414.
32. Tarantino C, Paolella G, Cozzuto L, Minopoli G, Pastore L, Parisi S, Russo T. miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells. FASEB J 2010; 25: 3255-3263.
33. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495-516.
34. Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008; 8: 266.
35. Chen QR, Yu LR, Tsang P, Wei JS, Song YK, Cheuk A, Chung JY, Hewitt SM, Veenstra TD, Khan J. Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a. J Proteome Res 2011; 10: 479-487.
36. Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P, Donohoe M, Luke MP, Calvao D, Grossman SR, Shi Y. Yin Yang 1 is a negative regulator of p53. Cell 2004; 117: 859-872.
37. Gronroos E, Terentiev AA, Punga T, Ericsson J. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci USA 2004; 101: 12165-12170.
38. Li YQ, Guessous F, Zhang Y, DiPierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang JM, Yang YZ, Schmittgen TD, Lopes B, Schiff D, Purow B, Abounader R. microRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 2009; 69: 7569-7576.
39. Katoh Y, Katoh M. Integrative genomic analyses on GLI2: mechanism of Hedgehog priming through basal GLI2 expression, and interaction map of stem cell signaling network with P53. Int J Oncol 2008; 33: 881-886.
40. Tivnan A, Tracey L, Buckley PG, Alcock LC, Davidoff AM, Stallings RL. MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma. BMC Cancer 2011; 11: 33-44.
41. Gueta K, Molotski N, Gerchikov N, Mor E, Savion S, Fein A, Toder V, Shomron N, Torchinsky A. Teratogen-induced alterations in microRNA-34, microRNA-125b and microRNA-155 expression: correlation with embryonic p53 genotype and limb phenotype. BMC Dev Biol 2010; 10: 20-29.
42. Pigazzi M, Manara E, Baron E, Basso G. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. Cancer Res 2009; 69: 2471-2478.
43. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-798.